{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T01:02:54Z","timestamp":1716080574802},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.endien.2023.12.002","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:52:50Z","timestamp":1711641170000},"page":"144-148","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report"],"prefix":"10.1016","volume":"71","author":[{"given":"Ana","family":"Pi\u00f1ar-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suset","family":"Due\u00f1as Disotuar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"de Lara-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Amuedo-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Cejudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Tejero-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Mangas-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2023.12.002_bib0165","doi-asserted-by":"crossref","first-page":"l1652","DOI":"10.1136\/bmj.l1652","article-title":"Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands","volume":"365","author":"de Blok","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.endien.2023.12.002_bib0170","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/jsm.12319","article-title":"Breast cancer development in transsexual subjects receiving cross-sex hormone treatment","volume":"10","author":"Gooren","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.endien.2023.12.002_bib0175","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.clbc.2018.11.007","article-title":"Interdisciplinary management of transgender individuals at risk for breast cancer: case reports and review of the literature","volume":"19","author":"Eismann","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.endien.2023.12.002_bib0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.critrevonc.2009.04.002","article-title":"Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases","volume":"73","author":"Cutuli","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.endien.2023.12.002_bib0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-008-0053-y","article-title":"The rising incidence of male breast cancer","volume":"115","author":"Speirs","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.endien.2023.12.002_bib0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12885-018-4098-y","article-title":"Male BRCA mutation carriers: clinical characteristics and cancer spectrum","volume":"18","author":"Ibrahim","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.endien.2023.12.002_bib0195","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endien.2023.12.002_bib0200","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.endien.2023.12.002_bib0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/ERC-16-0057","article-title":"Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation","volume":"23","author":"Corman","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.endien.2023.12.002_bib0210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.endien.2023.12.002_bib0215","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1086\/302678","article-title":"Founder BRCA1\/2 mutations among male patients with breast cancer in Israel","volume":"65","author":"Struewing","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.endien.2023.12.002_bib0220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/10906570050501579","article-title":"Genetic analyses of male breast cancer in Israel","volume":"4","author":"Sverdlov","year":"2000","journal-title":"Genet Test"},{"key":"10.1016\/j.endien.2023.12.002_bib0225","first-page":"313","article-title":"Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population","volume":"60","author":"Friedman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.endien.2023.12.002_bib0230","first-page":"995","article-title":"High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history","volume":"59","author":"Csokay","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.endien.2023.12.002_bib0235","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.endien.2023.12.002_bib0240","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.endien.2023.12.002_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.critrevonc.2016.02.017","article-title":"Male breast cancer is not congruent with the female disease","volume":"101","author":"Fentiman","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.endien.2023.12.002_bib0250","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2023.12.002_bib0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","article-title":"Incidence of breast cancer in a cohort of 5,135 transgender veterans","volume":"149","author":"Brown","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.endien.2023.12.002_bib0260","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ejso.2018.06.035","article-title":"Breast cancer in transgender patients: a systematic review. Part 1: Male to female","volume":"44","author":"Hartley","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.endien.2023.12.002_bib0265","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jsm.12628","article-title":"Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic","volume":"11","author":"Colebunders","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.endien.2023.12.002_bib0270","first-page":"270","volume":"vol. 5","author":"Wolf-Gould","year":"2018"},{"key":"10.1016\/j.endien.2023.12.002_bib0275","doi-asserted-by":"crossref","first-page":"e7161","DOI":"10.5867\/medwave.2018.04.7160","article-title":"Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers","volume":"18","author":"Honold","year":"2018","journal-title":"Medwave"},{"key":"10.1016\/j.endien.2023.12.002_bib0280","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2214\/AJR.13.10810","article-title":"Breast imaging in the transgender patient","volume":"202","author":"Phillips","year":"2014","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.endien.2023.12.002_bib0285","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0037-1604457","article-title":"Preventive health for transgender men and women","volume":"35","author":"Imborek","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.endien.2023.12.002_bib0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0037-1606103","article-title":"Breast cancer screening, management, and a review of case study literature in transgender populations","volume":"35","author":"Deutsch","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.endien.2023.12.002_bib0295","unstructured":"Lee S. As a trans woman do I need to get screened for breast cancer [Internet]. Canadian Cancer Society. Available from: https:\/\/cancer.ca\/en\/cancer-information\/find-cancer-early\/screening-in-lgbtq-communities\/as-a-trans-woman-do-i-need-to-get-screened-for-breast-cancer [cited 6.7.22]."},{"key":"10.1016\/j.endien.2023.12.002_bib0300","unstructured":"brca management for transgender women_413613_284_12069_v1.pdf [Internet]. Available from: https:\/\/www.yalecancercenter.org\/patient\/specialty\/genetics\/brca%20management%20for%20transgender%20women_413613_284_12069_v1.pdf [cited 6.7.22]."},{"key":"10.1016\/j.endien.2023.12.002_bib0305","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.3390\/ijms22073753","article-title":"Hereditary prostate cancer: genes related, target therapy and prevention","volume":"22","author":"Vietri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.endien.2023.12.002_bib0310","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/aja.2011.150","article-title":"The role of BRCA1 and BRCA2 in prostate cancer","volume":"14","author":"Castro","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.endien.2023.12.002_bib0315","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endien.2023.12.002_bib0320","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-023-01470-w","article-title":"Prostate cancer in transgender women: epidemiology, clinical characteristics, and management challenges","author":"Manfredi","year":"2023","journal-title":"Curr Oncol Rep"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T03:53:05Z","timestamp":1716004385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018024000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2530018024000271"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2023.12.002","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}